Pyxis Oncology prices Nasdaq IPO at $16/share
LONDON, UK: Arix Bioscience plc, a global venture capital company focused on investing in and building breakthrough biotech companies, notes that its portfolio company, Pyxis...
Malin Corporation’s investee Immunocore prices upsized Nasdaq IPO
DUBLIN: Malin Corporation notes that its investee company, Immunocore, has announced the pricing of its initial public offering (IPO) of 9.9 million American Depositary Shares...
Nanobiotix announces key development milestones for 2021 after successful Nasdaq IPO
PARIS: Nanobiotix announced its global development plan for 2021 and beyond. Nanobiotix is a clinical-stage biotechnology company focused on developing first-in-class product candidates that use...